Ventilator-associated pneumonia or not? Contemporary diagnosis

C. Glen Mayhall

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Ventilator-associated pneumonia (VAP) is pneumonia in patients who have been on mechanical ventilation for ≥48 hours. VAP is most accurately diagnosed by quantitative culture and microscopy examination of lower respiratory tract secretions, which are best obtained by bronchoscopically directed techniques such as the protected specimen brush and bronchoalveolar lavage. These techniques have acceptable repeatability, and interpretation of results is unaffected by antibiotics administered concurrently for infection at extrapulmonary sites as long as antimicrobial therapy has not been changed for <72 hours before bronchoscopy.

Original languageEnglish (US)
Pages (from-to)200-204
Number of pages5
JournalEmerging Infectious Diseases
Volume7
Issue number2
StatePublished - 2001

Fingerprint

Ventilator-Associated Pneumonia
Bronchoscopy
Bronchoalveolar Lavage
Artificial Respiration
Respiratory System
Microscopy
Pneumonia
Anti-Bacterial Agents
Infection
Therapeutics

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Ventilator-associated pneumonia or not? Contemporary diagnosis. / Mayhall, C. Glen.

In: Emerging Infectious Diseases, Vol. 7, No. 2, 2001, p. 200-204.

Research output: Contribution to journalArticle

Mayhall, C. Glen. / Ventilator-associated pneumonia or not? Contemporary diagnosis. In: Emerging Infectious Diseases. 2001 ; Vol. 7, No. 2. pp. 200-204.
@article{e2ebbda624db45029f415c5a3ac78961,
title = "Ventilator-associated pneumonia or not? Contemporary diagnosis",
abstract = "Ventilator-associated pneumonia (VAP) is pneumonia in patients who have been on mechanical ventilation for ≥48 hours. VAP is most accurately diagnosed by quantitative culture and microscopy examination of lower respiratory tract secretions, which are best obtained by bronchoscopically directed techniques such as the protected specimen brush and bronchoalveolar lavage. These techniques have acceptable repeatability, and interpretation of results is unaffected by antibiotics administered concurrently for infection at extrapulmonary sites as long as antimicrobial therapy has not been changed for <72 hours before bronchoscopy.",
author = "Mayhall, {C. Glen}",
year = "2001",
language = "English (US)",
volume = "7",
pages = "200--204",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "2",

}

TY - JOUR

T1 - Ventilator-associated pneumonia or not? Contemporary diagnosis

AU - Mayhall, C. Glen

PY - 2001

Y1 - 2001

N2 - Ventilator-associated pneumonia (VAP) is pneumonia in patients who have been on mechanical ventilation for ≥48 hours. VAP is most accurately diagnosed by quantitative culture and microscopy examination of lower respiratory tract secretions, which are best obtained by bronchoscopically directed techniques such as the protected specimen brush and bronchoalveolar lavage. These techniques have acceptable repeatability, and interpretation of results is unaffected by antibiotics administered concurrently for infection at extrapulmonary sites as long as antimicrobial therapy has not been changed for <72 hours before bronchoscopy.

AB - Ventilator-associated pneumonia (VAP) is pneumonia in patients who have been on mechanical ventilation for ≥48 hours. VAP is most accurately diagnosed by quantitative culture and microscopy examination of lower respiratory tract secretions, which are best obtained by bronchoscopically directed techniques such as the protected specimen brush and bronchoalveolar lavage. These techniques have acceptable repeatability, and interpretation of results is unaffected by antibiotics administered concurrently for infection at extrapulmonary sites as long as antimicrobial therapy has not been changed for <72 hours before bronchoscopy.

UR - http://www.scopus.com/inward/record.url?scp=0035038595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035038595&partnerID=8YFLogxK

M3 - Article

C2 - 11294706

AN - SCOPUS:0035038595

VL - 7

SP - 200

EP - 204

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 2

ER -